4.7 Article

Integrated DNA and RNA sequencing reveals early drivers involved in metastasis of gastric cancer

Journal

CELL DEATH & DISEASE
Volume 13, Issue 4, Pages -

Publisher

SPRINGERNATURE
DOI: 10.1038/s41419-022-04838-1

Keywords

-

Categories

Funding

  1. National Key R&D Program of China [2018YFC1313300]
  2. National Natural Science Foundation of China [81572331, 81772576, 81902425]
  3. National Science and Technology Major Project [2020ZX09201-013]

Ask authors/readers for more resources

Gastric cancer can be distinguished at the genetic level based on its metastatic potential, and we have identified potential driver mutations that promote metastasis. These mutations can facilitate metastasis by establishing an immunosuppressive microenvironment. This study provides possibilities for future targeted therapy of gastric cancer.
Gastric cancer (GC) is the second cause of cancer-related death and metastasis is an important cause of death. Considering difficulties in searching for metastatic driver mutations, we tried a novel strategy here. We conducted an integrative genomic analysis on GC and identified early drivers lead to metastasis. Whole-exome sequencing (WES), transcriptomes sequencing and targeted-exome sequencing (TES) were performed on tumors and matched normal tissues from 432 Chinese GC patients, especially the comparative analysis between higher metastatic-potential (HMP) group with T1 stage and lymph-node metastasis, and lower metastatic-potential (LMP) group without lymph-nodes or distant metastasis. HMP group presented higher mutation load and heterogeneity, enrichment in immunosuppressive signaling, more immune cell infiltration than LMP group. An integrated mRNA-lncRNA signature based on differentially expressed genes was constructed and its prognostic value was better than traditional TNM stage. We identified 176 candidate prometastatic mutations by WES and selected 8 genes for following TES. Mutated TP53 and MADCAM1 were significantly associated with poor metastasis-free survival. We further demonstrated that mutated MADCAM1 could not only directly promote cancer cells migration, but also could trigger tumor metastasis by establishing immunosuppressive microenvironment, including promoting PD-L1-mediated immune escape and reprogramming tumor-associated macrophages by regulating CCL2 through Akt/mTOR axis. In conclusion, GCs with different metastatic-potential are distinguishable at the genetic level and we revealed a number of potential metastatic driver mutations. Driver mutations in early-onset metastatic GC could promote metastasis by establishing an immunosuppressive microenvironment. This study provided possibility for future target therapy of GC.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available